Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | HM97662 |
Synonyms | |
Therapy Description |
HM97662 inhibits EZH1 and EZH2, potentially resulting in decreased tumor growth (Cancer Res (2021) 81 (13_Supplement):1142). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HM97662 | HM-97662|HM 97662 | EZH1 inhibitor 5 EZH2 inhibitor 20 | HM97662 inhibits EZH1 and EZH2, potentially resulting in decreased tumor growth (Cancer Res (2021) 81 (13_Supplement):1142). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05598151 | Phase I | HM97662 | Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | Recruiting | AUS | 1 |